

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.93687475 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.93687475 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.58981409 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.58981409 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.35796408 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26203177 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.84843661 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.84843661 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.84843661 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.62414377 |
| 11 | complement activation, alternative pathway (GO:0006957) | 5.56379347 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54272837 |
| 13 | urea metabolic process (GO:0019627) | 5.49688891 |
| 14 | urea cycle (GO:0000050) | 5.49688891 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.48638901 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.48546781 |
| 17 | regulation of plasminogen activation (GO:0010755) | 5.43724063 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.36907190 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.30811150 |
| 20 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 5.22957207 |
| 21 | * protein carboxylation (GO:0018214) | 5.22957207 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.22694663 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.18597670 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06498023 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.03686355 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 5.03465647 |
| 27 | negative regulation of protein activation cascade (GO:2000258) | 4.96858265 |
| 28 | regulation of cholesterol esterification (GO:0010872) | 4.93265790 |
| 29 | reverse cholesterol transport (GO:0043691) | 4.91127273 |
| 30 | epoxygenase P450 pathway (GO:0019373) | 4.88996952 |
| 31 | regulation of complement activation (GO:0030449) | 4.88800195 |
| 32 | plasma lipoprotein particle remodeling (GO:0034369) | 4.88044622 |
| 33 | protein-lipid complex remodeling (GO:0034368) | 4.88044622 |
| 34 | macromolecular complex remodeling (GO:0034367) | 4.88044622 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 4.80733461 |
| 36 | cysteine metabolic process (GO:0006534) | 4.78124412 |
| 37 | phospholipid efflux (GO:0033700) | 4.75033477 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 4.75027226 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.70531151 |
| 40 | bile acid metabolic process (GO:0008206) | 4.67203477 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.62023000 |
| 42 | exogenous drug catabolic process (GO:0042738) | 4.58131765 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.56492913 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.49733684 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.41164126 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.36985414 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.36985414 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.36811907 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.36089318 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.36089318 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.35770138 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.35770138 |
| 53 | cholesterol efflux (GO:0033344) | 4.34404107 |
| 54 | aldehyde catabolic process (GO:0046185) | 4.29037522 |
| 55 | low-density lipoprotein particle remodeling (GO:0034374) | 4.21799514 |
| 56 | negative regulation of complement activation (GO:0045916) | 4.20712487 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.18245142 |
| 58 | amine catabolic process (GO:0009310) | 4.14102170 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.14102170 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.12973197 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.12940052 |
| 62 | fibrinolysis (GO:0042730) | 4.08811718 |
| 63 | negative regulation of coagulation (GO:0050819) | 4.06634778 |
| 64 | plasma lipoprotein particle assembly (GO:0034377) | 4.04638254 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.01009800 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 3.98653847 |
| 67 | negative regulation of wound healing (GO:0061045) | 3.98375272 |
| 68 | phenylpropanoid metabolic process (GO:0009698) | 3.98195461 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.95708785 |
| 70 | cellular glucuronidation (GO:0052695) | 3.91728091 |
| 71 | omega-hydroxylase P450 pathway (GO:0097267) | 3.91484014 |
| 72 | arginine metabolic process (GO:0006525) | 3.88599129 |
| 73 | regulation of bile acid biosynthetic process (GO:0070857) | 3.87576301 |
| 74 | lysine metabolic process (GO:0006553) | 3.87541240 |
| 75 | lysine catabolic process (GO:0006554) | 3.87541240 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.86981276 |
| 77 | cofactor catabolic process (GO:0051187) | 3.86745462 |
| 78 | glycine metabolic process (GO:0006544) | 3.85395684 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.83094035 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82946319 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82946319 |
| 82 | acute-phase response (GO:0006953) | 3.81462275 |
| 83 | positive regulation of lipid catabolic process (GO:0050996) | 3.81314629 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 3.80523848 |
| 85 | cellular amino acid catabolic process (GO:0009063) | 3.80026642 |
| 86 | opsonization (GO:0008228) | 3.79699334 |
| 87 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.79481432 |
| 88 | regulation of humoral immune response (GO:0002920) | 3.78784100 |
| 89 | positive regulation of hemostasis (GO:1900048) | 3.76687713 |
| 90 | positive regulation of blood coagulation (GO:0030194) | 3.76687713 |
| 91 | drug metabolic process (GO:0017144) | 3.76231472 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.76117225 |
| 93 | glutamate metabolic process (GO:0006536) | 3.74146406 |
| 94 | complement activation (GO:0006956) | 3.71992124 |
| 95 | regulation of apoptotic cell clearance (GO:2000425) | 3.71274079 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70718690 |
| 97 | cholesterol transport (GO:0030301) | 3.69338182 |
| 98 | sterol transport (GO:0015918) | 3.69338182 |
| 99 | ethanol metabolic process (GO:0006067) | 3.69330405 |
| 100 | * protein activation cascade (GO:0072376) | 3.68046622 |
| 101 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67467191 |
| 102 | NAD biosynthetic process (GO:0009435) | 3.67075976 |
| 103 | positive regulation of coagulation (GO:0050820) | 3.65823861 |
| 104 | serine family amino acid metabolic process (GO:0009069) | 3.64674224 |
| 105 | protein-lipid complex assembly (GO:0065005) | 3.64000119 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.63862175 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.59962591 |
| 108 | cellular modified amino acid catabolic process (GO:0042219) | 3.58990073 |
| 109 | protein-lipid complex subunit organization (GO:0071825) | 3.58483279 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.58398324 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.58398324 |
| 112 | ethanol oxidation (GO:0006069) | 3.58257499 |
| 113 | sterol homeostasis (GO:0055092) | 3.58122513 |
| 114 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.54486971 |
| 115 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54486971 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.51887602 |
| 117 | drug catabolic process (GO:0042737) | 3.49815085 |
| 118 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.49566256 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.45345263 |
| 120 | positive regulation of steroid metabolic process (GO:0045940) | 3.44904025 |
| 121 | lipoprotein metabolic process (GO:0042157) | 3.43443606 |
| 122 | ketone body metabolic process (GO:1902224) | 3.40749007 |
| 123 | serine family amino acid biosynthetic process (GO:0009070) | 3.40496876 |
| 124 | organic acid catabolic process (GO:0016054) | 3.33140383 |
| 125 | regulation of lipoprotein particle clearance (GO:0010984) | 3.31975439 |
| 126 | proline metabolic process (GO:0006560) | 3.31440330 |
| 127 | oxidative demethylation (GO:0070989) | 3.30776597 |
| 128 | intestinal absorption (GO:0050892) | 3.24699646 |
| 129 | heme transport (GO:0015886) | 3.23411004 |
| 130 | negative regulation of humoral immune response (GO:0002921) | 3.16382706 |
| 131 | lipid homeostasis (GO:0055088) | 3.13580504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.66274291 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.78033608 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.55138194 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99945713 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.87904752 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.87703923 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30579581 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.76028356 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57034774 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.88874068 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47278375 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17191221 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.11593038 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9080034 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87497651 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83626973 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71638424 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66715785 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66288594 |
| 20 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65785887 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60191869 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49928504 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46838437 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46651095 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44115686 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43089242 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41470836 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40283225 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40199135 |
| 30 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39492093 |
| 31 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.38062037 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30982472 |
| 33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21800124 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21120236 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21092436 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17313042 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15575121 |
| 38 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13087265 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10162256 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09707023 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07168242 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00162320 |
| 43 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97214999 |
| 44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97034616 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93720226 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90370384 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90370384 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89249457 |
| 49 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89032621 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88312613 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87487753 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86713677 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86383470 |
| 54 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85830209 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84437532 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.81558102 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.81107366 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80942001 |
| 59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80932739 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79154256 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78927957 |
| 62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78617345 |
| 63 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77714507 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77348459 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76575380 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75901018 |
| 67 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.75583812 |
| 68 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75215519 |
| 69 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.74875345 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74713636 |
| 71 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.72835076 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 0.71859698 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.70506571 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70459188 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.69871859 |
| 76 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.69518651 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69310287 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68596243 |
| 79 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.68513483 |
| 80 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68418279 |
| 81 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.67950640 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.67532474 |
| 83 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67321372 |
| 84 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.66953894 |
| 85 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66951113 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66724338 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.66215507 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66043112 |
| 89 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.65297414 |
| 90 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.64760495 |
| 91 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64155122 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64058383 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63826139 |
| 94 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.63612451 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.63490839 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62986928 |
| 97 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.61898816 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.61658775 |
| 99 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61396243 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61334289 |
| 101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60742799 |
| 102 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60663397 |
| 103 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.60544382 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60355844 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.60148145 |
| 106 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59548178 |
| 107 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.59350748 |
| 108 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.59345209 |
| 109 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59288792 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59235115 |
| 111 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.59232002 |
| 112 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.59219524 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58507298 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.58303784 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.57883964 |
| 116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.57291475 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57095873 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55650993 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.54703289 |
| 120 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.54357093 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54034160 |
| 122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52946859 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52633506 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52255903 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52165662 |
| 126 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.51701762 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51032080 |
| 128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50060620 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50030945 |
| 130 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49904883 |
| 131 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.49496419 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.49207064 |
| 133 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47608692 |
| 134 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.46811491 |
| 135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.46501908 |
| 136 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.46077481 |
| 137 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.46014418 |
| 138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45692034 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.44806790 |
| 140 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44759993 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44727308 |
| 142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.44403437 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.44329339 |
| 144 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.44259140 |
| 145 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44130305 |
| 146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44119250 |
| 147 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.42909974 |
| 148 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.42730346 |
| 149 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.42320538 |
| 150 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42285444 |
| 151 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41577904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.60849401 |
| 2 | MP0005360_urolithiasis | 6.92639695 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.78236045 |
| 4 | MP0005365_abnormal_bile_salt | 5.51375249 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.54521388 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.90418977 |
| 7 | MP0009840_abnormal_foam_cell | 3.53363881 |
| 8 | MP0003252_abnormal_bile_duct | 3.46110085 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.35845522 |
| 10 | MP0003195_calcinosis | 2.98806655 |
| 11 | MP0005083_abnormal_biliary_tract | 2.90224566 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.66034687 |
| 13 | MP0003122_maternal_imprinting | 2.59900325 |
| 14 | MP0005332_abnormal_amino_acid | 2.53062316 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.29187014 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.18584359 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.10183583 |
| 18 | MP0000609_abnormal_liver_physiology | 2.09969215 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.04349542 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.98151303 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.82228740 |
| 22 | MP0005451_abnormal_body_composition | 1.72658058 |
| 23 | MP0001764_abnormal_homeostasis | 1.66549855 |
| 24 | MP0003436_decreased_susceptibility_to | 1.61584132 |
| 25 | MP0003868_abnormal_feces_composition | 1.58230093 |
| 26 | MP0009764_decreased_sensitivity_to | 1.56024541 |
| 27 | MP0003186_abnormal_redox_activity | 1.55903774 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53637635 |
| 29 | MP0003011_delayed_dark_adaptation | 1.52292829 |
| 30 | MP0006054_spinal_hemorrhage | 1.51570887 |
| 31 | MP0009697_abnormal_copulation | 1.50536482 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.48014538 |
| 33 | MP0005379_endocrine/exocrine_gland_phen | 1.47510402 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.45583914 |
| 35 | MP0003724_increased_susceptibility_to | 1.39670862 |
| 36 | MP0000604_amyloidosis | 1.38066099 |
| 37 | MP0008469_abnormal_protein_level | 1.33514901 |
| 38 | MP0003123_paternal_imprinting | 1.27869489 |
| 39 | MP0009763_increased_sensitivity_to | 1.25632609 |
| 40 | MP0009785_altered_susceptibility_to | 1.23734394 |
| 41 | MP0006082_CNS_inflammation | 1.20125956 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.19738451 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.19401263 |
| 44 | MP0000598_abnormal_liver_morphology | 1.17012136 |
| 45 | MP0001915_intracranial_hemorrhage | 1.16051216 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.10981879 |
| 47 | MP0002419_abnormal_innate_immunity | 1.09240823 |
| 48 | MP0002254_reproductive_system_inflammat | 1.08139328 |
| 49 | MP0005647_abnormal_sex_gland | 1.06687023 |
| 50 | MP0003879_abnormal_hair_cell | 1.03916413 |
| 51 | MP0003690_abnormal_glial_cell | 1.03608769 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.02346922 |
| 53 | MP0005025_abnormal_response_to | 1.02290306 |
| 54 | MP0004272_abnormal_basement_membrane | 1.02161615 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.00978379 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 0.97826046 |
| 57 | MP0003075_altered_response_to | 0.96189864 |
| 58 | MP0000566_synostosis | 0.93890456 |
| 59 | MP0005058_abnormal_lysosome_morphology | 0.93529253 |
| 60 | MP0003303_peritoneal_inflammation | 0.90943681 |
| 61 | * MP0009642_abnormal_blood_homeostasis | 0.90264142 |
| 62 | MP0001944_abnormal_pancreas_morphology | 0.89590368 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 0.89118660 |
| 64 | MP0005408_hypopigmentation | 0.89057855 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.84595280 |
| 66 | MP0000003_abnormal_adipose_tissue | 0.83956444 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.83101674 |
| 68 | MP0001845_abnormal_inflammatory_respons | 0.81985697 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 0.81917687 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.80906331 |
| 71 | * MP0005636_abnormal_mineral_homeostasis | 0.79686868 |
| 72 | MP0001853_heart_inflammation | 0.78414328 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 0.76756651 |
| 74 | MP0005166_decreased_susceptibility_to | 0.74796457 |
| 75 | MP0005535_abnormal_body_temperature | 0.74625247 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 0.73233854 |
| 77 | MP0002876_abnormal_thyroid_physiology | 0.72205272 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.70470867 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.69572523 |
| 80 | MP0002971_abnormal_brown_adipose | 0.69278476 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.68634295 |
| 82 | MP0005000_abnormal_immune_tolerance | 0.67922209 |
| 83 | MP0005334_abnormal_fat_pad | 0.67831310 |
| 84 | MP0003953_abnormal_hormone_level | 0.67391123 |
| 85 | MP0000685_abnormal_immune_system | 0.66622968 |
| 86 | MP0004947_skin_inflammation | 0.65235583 |
| 87 | MP0001790_abnormal_immune_system | 0.64948139 |
| 88 | MP0005387_immune_system_phenotype | 0.64948139 |
| 89 | MP0004130_abnormal_muscle_cell | 0.64360808 |
| 90 | MP0002090_abnormal_vision | 0.63620774 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.63547959 |
| 92 | MP0009384_cardiac_valve_regurgitation | 0.62569707 |
| 93 | MP0005187_abnormal_penis_morphology | 0.62451300 |
| 94 | MP0005670_abnormal_white_adipose | 0.62434133 |
| 95 | MP0003329_amyloid_beta_deposits | 0.62230585 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 0.62021324 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.59781672 |
| 98 | MP0005257_abnormal_intraocular_pressure | 0.57664278 |
| 99 | MP0005164_abnormal_response_to | 0.56805018 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.56752060 |
| 101 | MP0001800_abnormal_humoral_immune | 0.56661434 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.55769983 |
| 103 | MP0008873_increased_physiological_sensi | 0.55449905 |
| 104 | MP0005409_darkened_coat_color | 0.54363856 |
| 105 | MP0002723_abnormal_immune_serum | 0.54056390 |
| 106 | MP0001756_abnormal_urination | 0.53427920 |
| 107 | MP0005220_abnormal_exocrine_pancreas | 0.53110331 |
| 108 | MP0000249_abnormal_blood_vessel | 0.53028460 |
| 109 | MP0005448_abnormal_energy_balance | 0.52974463 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.52794822 |
| 111 | MP0003121_genomic_imprinting | 0.52582837 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.51402776 |
| 113 | MP0005266_abnormal_metabolism | 0.50900188 |
| 114 | MP0002938_white_spotting | 0.50785620 |
| 115 | MP0004270_analgesia | 0.50681874 |
| 116 | MP0004883_abnormal_blood_vessel | 0.49700221 |
| 117 | MP0002168_other_aberrant_phenotype | 0.49510283 |
| 118 | MP0004381_abnormal_hair_follicle | 0.49334212 |
| 119 | MP0001661_extended_life_span | 0.48830684 |
| 120 | MP0004133_heterotaxia | 0.48733347 |
| 121 | MP0005395_other_phenotype | 0.48340957 |
| 122 | MP0003633_abnormal_nervous_system | 0.47998623 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.47502259 |
| 124 | MP0002163_abnormal_gland_morphology | 0.46071440 |
| 125 | MP0005646_abnormal_pituitary_gland | 0.45585353 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.45571749 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.45198588 |
| 128 | MP0002132_abnormal_respiratory_system | 0.44014270 |
| 129 | MP0008874_decreased_physiological_sensi | 0.43868852 |
| 130 | MP0003718_maternal_effect | 0.42215599 |
| 131 | MP0009053_abnormal_anal_canal | 0.42165136 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.41177664 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.39933321 |
| 134 | MP0002928_abnormal_bile_duct | 0.39006903 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.37993416 |
| 136 | MP0001270_distended_abdomen | 0.37929633 |
| 137 | MP0003632_abnormal_nervous_system | 0.36846292 |
| 138 | MP0002933_joint_inflammation | 0.36524035 |
| 139 | MP0005023_abnormal_wound_healing | 0.36475969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.11408321 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.83638371 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.73170398 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.25278640 |
| 5 | * Prolonged partial thromboplastin time (HP:0003645) | 6.20658307 |
| 6 | Xanthomatosis (HP:0000991) | 6.01254490 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.79762554 |
| 8 | Complement deficiency (HP:0004431) | 5.41404402 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.27342685 |
| 10 | * Joint hemorrhage (HP:0005261) | 4.90508132 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.42371221 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.41450129 |
| 13 | Epidermoid cyst (HP:0200040) | 4.32955756 |
| 14 | Abnormality of complement system (HP:0005339) | 4.21052301 |
| 15 | * Abnormality of the common coagulation pathway (HP:0010990) | 4.19321685 |
| 16 | Hyperammonemia (HP:0001987) | 4.13494153 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10923638 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.02508613 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.96930574 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96701995 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.96555894 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.94699232 |
| 23 | Fat malabsorption (HP:0002630) | 3.89100522 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82115679 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.78312144 |
| 26 | Hyperglycinemia (HP:0002154) | 3.68272602 |
| 27 | Ketosis (HP:0001946) | 3.65079440 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.61109199 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60792271 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.45850501 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.41958926 |
| 32 | Hyperglycinuria (HP:0003108) | 3.30454244 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.28465838 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.28465838 |
| 35 | Myocardial infarction (HP:0001658) | 3.28209232 |
| 36 | Glomerulonephritis (HP:0000099) | 3.25706478 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.10056358 |
| 38 | Steatorrhea (HP:0002570) | 3.02772586 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.02543806 |
| 40 | Spontaneous abortion (HP:0005268) | 3.01508578 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.01179640 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95358130 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.86740934 |
| 44 | Amyloidosis (HP:0011034) | 2.73639755 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.68044944 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.65396181 |
| 47 | Arthropathy (HP:0003040) | 2.65142927 |
| 48 | Vascular calcification (HP:0004934) | 2.64687428 |
| 49 | Skin nodule (HP:0200036) | 2.59368947 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.59216517 |
| 51 | Purpura (HP:0000979) | 2.55464759 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.51979355 |
| 53 | Metabolic acidosis (HP:0001942) | 2.47526132 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47078748 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.47078748 |
| 56 | Mitral stenosis (HP:0001718) | 2.45996160 |
| 57 | Ketoacidosis (HP:0001993) | 2.42299246 |
| 58 | * Gingival bleeding (HP:0000225) | 2.39301086 |
| 59 | Acanthocytosis (HP:0001927) | 2.38718441 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38402298 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38402298 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38402298 |
| 63 | Esophageal varix (HP:0002040) | 2.38195384 |
| 64 | Thrombophlebitis (HP:0004418) | 2.37329624 |
| 65 | Eczematoid dermatitis (HP:0000976) | 2.34817601 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.31377473 |
| 67 | Nephritis (HP:0000123) | 2.30597837 |
| 68 | Hemorrhage of the eye (HP:0011885) | 2.29992919 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.29492625 |
| 70 | Abnormality of the Achilles tendon (HP:0005109) | 2.29130933 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.25414462 |
| 72 | Retinal atrophy (HP:0001105) | 2.25354088 |
| 73 | Lethargy (HP:0001254) | 2.24634014 |
| 74 | Osteomalacia (HP:0002749) | 2.24450137 |
| 75 | Pancreatitis (HP:0001733) | 2.23775457 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22932852 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.22932852 |
| 78 | Cholelithiasis (HP:0001081) | 2.20303111 |
| 79 | Spastic diplegia (HP:0001264) | 2.20282975 |
| 80 | Irritability (HP:0000737) | 2.20112915 |
| 81 | Late onset (HP:0003584) | 2.15964445 |
| 82 | Recurrent bacterial skin infections (HP:0005406) | 2.13202759 |
| 83 | * Menorrhagia (HP:0000132) | 2.12603759 |
| 84 | Proximal tubulopathy (HP:0000114) | 2.11164249 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.10785360 |
| 86 | Abnormality of vitamin metabolism (HP:0100508) | 2.10334978 |
| 87 | Pulmonary embolism (HP:0002204) | 2.09862109 |
| 88 | Cerebral edema (HP:0002181) | 2.08978765 |
| 89 | Abnormal delivery (HP:0001787) | 2.08555979 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.07503572 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 2.05931475 |
| 92 | Glycosuria (HP:0003076) | 2.05931475 |
| 93 | Cholecystitis (HP:0001082) | 2.05282089 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.05282089 |
| 95 | Axonal loss (HP:0003447) | 2.03006046 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.00352857 |
| 97 | Opisthotonus (HP:0002179) | 1.99710329 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99592825 |
| 99 | Neonatal onset (HP:0003623) | 1.98988190 |
| 100 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.98722147 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.98301052 |
| 102 | Abnormality of carpal bone ossification (HP:0006257) | 1.97832470 |
| 103 | Nausea (HP:0002018) | 1.95044256 |
| 104 | Back pain (HP:0003418) | 1.93876621 |
| 105 | Hypothermia (HP:0002045) | 1.93624843 |
| 106 | Generalized aminoaciduria (HP:0002909) | 1.92786362 |
| 107 | Poikilocytosis (HP:0004447) | 1.91050109 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90805615 |
| 109 | Joint swelling (HP:0001386) | 1.90499663 |
| 110 | Pigmentary retinal degeneration (HP:0001146) | 1.89420291 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.89318029 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.89318029 |
| 113 | Hyperglycemia (HP:0003074) | 1.88936393 |
| 114 | Vomiting (HP:0002013) | 1.88050915 |
| 115 | Rickets (HP:0002748) | 1.87664266 |
| 116 | Facial shape deformation (HP:0011334) | 1.86212019 |
| 117 | Potter facies (HP:0002009) | 1.86212019 |
| 118 | Gout (HP:0001997) | 1.85218548 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 1.84345094 |
| 120 | Enlarged kidneys (HP:0000105) | 1.83772135 |
| 121 | Malnutrition (HP:0004395) | 1.82652195 |
| 122 | Elevated hepatic transaminases (HP:0002910) | 1.80654546 |
| 123 | Elevated alkaline phosphatase (HP:0003155) | 1.80242632 |
| 124 | Upper motor neuron abnormality (HP:0002127) | 1.79906186 |
| 125 | Abnormal tarsal ossification (HP:0008369) | 1.79667177 |
| 126 | Renal cortical cysts (HP:0000803) | 1.79504670 |
| 127 | Fair hair (HP:0002286) | 1.75759353 |
| 128 | Hyperphosphaturia (HP:0003109) | 1.68039092 |
| 129 | Increased serum pyruvate (HP:0003542) | 1.64528642 |
| 130 | Broad alveolar ridges (HP:0000187) | 1.63466105 |
| 131 | Abnormality of the vitreous humor (HP:0004327) | 1.62057373 |
| 132 | Reduced antithrombin III activity (HP:0001976) | 1.59453425 |
| 133 | Dysostosis multiplex (HP:0000943) | 1.54428184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.85786622 |
| 2 | ERN1 | 4.10751138 |
| 3 | FGFR4 | 3.66714237 |
| 4 | TAOK3 | 3.28528201 |
| 5 | SIK1 | 3.27202675 |
| 6 | MST1R | 3.05189001 |
| 7 | MAP3K14 | 3.03007642 |
| 8 | PBK | 2.86612879 |
| 9 | WNK4 | 2.86014997 |
| 10 | TYK2 | 2.58826784 |
| 11 | TBK1 | 2.57199248 |
| 12 | ERBB4 | 2.54288036 |
| 13 | BLK | 2.39647582 |
| 14 | INSRR | 2.30659210 |
| 15 | IRAK3 | 2.01300452 |
| 16 | NTRK3 | 2.00220554 |
| 17 | PIK3CA | 1.91673515 |
| 18 | ABL2 | 1.88098615 |
| 19 | CASK | 1.87625574 |
| 20 | RIPK4 | 1.78786739 |
| 21 | ICK | 1.74738633 |
| 22 | MYLK | 1.73555257 |
| 23 | MAP4K2 | 1.68231428 |
| 24 | IKBKE | 1.67364098 |
| 25 | PDGFRA | 1.67083793 |
| 26 | AKT3 | 1.66321571 |
| 27 | PDK2 | 1.65655915 |
| 28 | JAK1 | 1.63940062 |
| 29 | IRAK4 | 1.61982429 |
| 30 | PIK3CG | 1.56668810 |
| 31 | EIF2AK1 | 1.56408950 |
| 32 | EPHB1 | 1.54682573 |
| 33 | FGFR1 | 1.51543707 |
| 34 | MAP2K6 | 1.48423921 |
| 35 | PHKG2 | 1.48364367 |
| 36 | PHKG1 | 1.48364367 |
| 37 | DAPK2 | 1.44910928 |
| 38 | EPHA4 | 1.43800152 |
| 39 | CSK | 1.41759029 |
| 40 | JAK2 | 1.40122768 |
| 41 | NEK9 | 1.39811540 |
| 42 | MAPK11 | 1.36216467 |
| 43 | FLT3 | 1.35651241 |
| 44 | MAP2K4 | 1.35580263 |
| 45 | PKN2 | 1.28478979 |
| 46 | IKBKB | 1.25752269 |
| 47 | PRKCG | 1.25148651 |
| 48 | WNK3 | 1.22129239 |
| 49 | MAP4K1 | 1.15860300 |
| 50 | NLK | 1.11943445 |
| 51 | BMX | 1.11858331 |
| 52 | MAP3K11 | 1.11777808 |
| 53 | MET | 1.11659474 |
| 54 | PTK6 | 1.10520654 |
| 55 | MAP2K3 | 1.04070082 |
| 56 | TRIB3 | 1.03137433 |
| 57 | KDR | 1.00232992 |
| 58 | FER | 1.00079256 |
| 59 | WNK1 | 0.99693997 |
| 60 | MUSK | 0.99597731 |
| 61 | JAK3 | 0.98651174 |
| 62 | EPHA3 | 0.97358311 |
| 63 | PTK2 | 0.96244694 |
| 64 | MAPKAPK3 | 0.95320868 |
| 65 | MAP3K2 | 0.93922300 |
| 66 | GRK6 | 0.93242755 |
| 67 | DDR2 | 0.91491139 |
| 68 | RET | 0.88410636 |
| 69 | TRPM7 | 0.87567690 |
| 70 | KIT | 0.86716445 |
| 71 | ADRBK2 | 0.85588610 |
| 72 | MAP3K12 | 0.85566091 |
| 73 | TXK | 0.85331811 |
| 74 | CSF1R | 0.82987661 |
| 75 | PRKCE | 0.82978507 |
| 76 | MAPK4 | 0.82360347 |
| 77 | STK38L | 0.82281465 |
| 78 | CDC42BPA | 0.81829587 |
| 79 | TYRO3 | 0.80339667 |
| 80 | PRKAA1 | 0.78134919 |
| 81 | MAP3K13 | 0.76460336 |
| 82 | PRKG1 | 0.75478345 |
| 83 | PAK3 | 0.74023650 |
| 84 | PRKAA2 | 0.72405480 |
| 85 | CSNK1D | 0.72362207 |
| 86 | ACVR1B | 0.71964438 |
| 87 | CHUK | 0.70872081 |
| 88 | PRKCZ | 0.70562317 |
| 89 | LYN | 0.69493219 |
| 90 | ERBB2 | 0.69479722 |
| 91 | MAP3K3 | 0.69268865 |
| 92 | PRKCQ | 0.68943533 |
| 93 | STK38 | 0.67441884 |
| 94 | PINK1 | 0.67317199 |
| 95 | TAOK2 | 0.67245836 |
| 96 | IRAK1 | 0.67140229 |
| 97 | CSNK1E | 0.66885952 |
| 98 | CDK12 | 0.66597274 |
| 99 | SGK1 | 0.64844511 |
| 100 | ZAP70 | 0.64078678 |
| 101 | TGFBR2 | 0.63777308 |
| 102 | BTK | 0.62532746 |
| 103 | IRAK2 | 0.62402550 |
| 104 | PKN1 | 0.61871761 |
| 105 | PRKACG | 0.61774004 |
| 106 | LATS1 | 0.61576527 |
| 107 | PRKD3 | 0.61015078 |
| 108 | SYK | 0.60938354 |
| 109 | CSNK1G1 | 0.60770997 |
| 110 | CAMK1D | 0.59872356 |
| 111 | MAP3K5 | 0.59846606 |
| 112 | MAPK12 | 0.58795027 |
| 113 | FRK | 0.56435149 |
| 114 | CAMK2D | 0.55661396 |
| 115 | FGFR3 | 0.55570762 |
| 116 | PRKACB | 0.55499815 |
| 117 | EGFR | 0.55437293 |
| 118 | STK3 | 0.55101663 |
| 119 | SGK494 | 0.54792686 |
| 120 | SGK223 | 0.54792686 |
| 121 | GSK3A | 0.54403914 |
| 122 | HCK | 0.54337258 |
| 123 | PRKG2 | 0.54332121 |
| 124 | MAP3K10 | 0.53633887 |
| 125 | PDPK1 | 0.53598569 |
| 126 | RIPK1 | 0.52205297 |
| 127 | LMTK2 | 0.52071600 |
| 128 | MAP3K7 | 0.51850102 |
| 129 | ABL1 | 0.51189361 |
| 130 | CDK6 | 0.51013525 |
| 131 | PRKACA | 0.50464593 |
| 132 | PRKCD | 0.49444782 |
| 133 | CAMK2G | 0.47868999 |
| 134 | NEK1 | 0.47749297 |
| 135 | RPS6KB1 | 0.45543493 |
| 136 | IGF1R | 0.45438158 |
| 137 | GRK1 | 0.45335405 |
| 138 | MST4 | 0.45211072 |
| 139 | MAP3K1 | 0.44583468 |
| 140 | SRC | 0.42726583 |
| 141 | NME2 | 0.42391654 |
| 142 | TIE1 | 0.42201810 |
| 143 | EIF2AK2 | 0.40893554 |
| 144 | BMPR2 | 0.39993551 |
| 145 | FGFR2 | 0.39782892 |
| 146 | AKT2 | 0.38361945 |
| 147 | STK24 | 0.37954565 |
| 148 | CSNK1A1 | 0.37939776 |
| 149 | LCK | 0.37909734 |
| 150 | SGK3 | 0.37451508 |
| 151 | PRKCB | 0.36718856 |
| 152 | RPS6KA3 | 0.36711761 |
| 153 | CSNK1A1L | 0.36337791 |
| 154 | LIMK1 | 0.35772160 |
| 155 | PIM1 | 0.35545060 |
| 156 | FGR | 0.35444611 |
| 157 | DYRK1B | 0.35267695 |
| 158 | PDK1 | 0.34803034 |
| 159 | MAPK7 | 0.33996540 |
| 160 | MATK | 0.33165274 |
| 161 | STK4 | 0.33036582 |
| 162 | TEC | 0.32534726 |
| 163 | CDK4 | 0.30000706 |
| 164 | MAPK15 | 0.28801935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.48820580 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42923497 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29213598 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27448322 |
| 5 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.10557559 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08481785 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64064551 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60013280 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54814209 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41199399 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34450514 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34395503 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30935006 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17824797 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11329721 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09693222 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03446911 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94285304 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94162849 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91065311 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90713994 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83562548 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80630898 |
| 24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71165492 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70139028 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69330617 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66987872 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63294153 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56288591 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53962916 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52019319 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47830532 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47745801 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.45371693 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37058931 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36490829 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.33369967 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30102180 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29274050 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26933827 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.23930270 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20172206 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19045579 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17100393 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11065426 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08432289 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07897689 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05895547 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00340013 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95223766 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93718707 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92978134 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91303283 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86211207 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85982052 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81443426 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74372735 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66668471 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.65871778 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65796751 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64151278 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59826512 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59296942 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58572043 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56340586 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.51142873 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50109734 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48937497 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47982900 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47527981 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43686282 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.42256042 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40204044 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37438502 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.28301063 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28055099 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28037623 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27696286 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23965746 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23933300 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.23508608 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22514125 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.21948839 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21897319 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.21461107 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.19311516 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18928130 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.18288874 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18258929 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.18010174 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16582014 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16092696 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15561783 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15351103 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13359475 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.10976505 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.09138092 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07166180 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.05189336 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.04410204 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.03299963 |
| 102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.02999993 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.02344874 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.02091502 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01480608 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.01023655 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00994886 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.00320475 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.00077944 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0409646 |
| 111 | Asthma_Homo sapiens_hsa05310 | -0.0336487 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | -0.0250474 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0245947 |
| 114 | Insulin secretion_Homo sapiens_hsa04911 | -0.0196289 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0162395 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0134851 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | -0.0001261 |

